Iron supplementation reduces coronary heart failure (HF) readmissions in iron-deficient patients hospitalized for acute HF, per outcomes of the AFFIRM-AHF trial. After 52 weeks, intravenous…
Iron supplementation reduces coronary heart failure (HF) readmissions in iron-deficient patients hospitalized for acute HF, per outcomes of the AFFIRM-AHF trial. After 52 weeks, intravenous…